These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 27109935)

  • 21. Expression and methylation patterns partition luminal-A breast tumors into distinct prognostic subgroups.
    Netanely D; Avraham A; Ben-Baruch A; Evron E; Shamir R
    Breast Cancer Res; 2016 Jul; 18(1):74. PubMed ID: 27386846
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conservation of immune gene signatures in solid tumors and prognostic implications.
    Chifman J; Pullikuth A; Chou JW; Bedognetti D; Miller LD
    BMC Cancer; 2016 Nov; 16(1):911. PubMed ID: 27871313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
    Pécuchet N; Legras A; Laurent-Puig P; Blons H
    Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) - associations with gene expression, mutational load, and survival.
    Budczies J; Bockmayr M; Denkert C; Klauschen F; Gröschel S; Darb-Esfahani S; Pfarr N; Leichsenring J; Onozato ML; Lennerz JK; Dietel M; Fröhling S; Schirmacher P; Iafrate AJ; Weichert W; Stenzinger A
    Genes Chromosomes Cancer; 2016 Aug; 55(8):626-39. PubMed ID: 27106868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA methylation mediated silencing of microRNA-874 is a promising diagnosis and prognostic marker in breast cancer.
    Zhang L; Yan DL; Yang F; Wang DD; Chen X; Wu JZ; Tang JH; Xia WJ
    Oncotarget; 2017 Jul; 8(28):45496-45505. PubMed ID: 28525377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.
    Son JW; Jeong KJ; Jean WS; Park SY; Jheon S; Cho HM; Park CG; Lee HY; Kang J
    Cancer Lett; 2011 Dec; 311(1):29-37. PubMed ID: 21757291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MCNF: A Novel Method for Cancer Subtyping by Integrating Multi-Omics and Clinical Data.
    Zhao L; Yan H
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(5):1682-1690. PubMed ID: 30990192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Global, cancer-specific microRNA cluster hypomethylation was functionally associated with the development of non-B non-C hepatocellular carcinoma.
    Nojima M; Matsui T; Tamori A; Kubo S; Shirabe K; Kimura K; Shimada M; Utsunomiya T; Kondo Y; Iio E; Naito Y; Ochiya T; Tanaka Y
    Mol Cancer; 2016 Apr; 15(1):31. PubMed ID: 27137948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of between-tissue differences on pan-cancer predictions of drug sensitivity.
    Lloyd JP; Soellner MB; Merajver SD; Li JZ
    PLoS Comput Biol; 2021 Feb; 17(2):e1008720. PubMed ID: 33630864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrative clustering of multi-level 'omic data based on non-negative matrix factorization algorithm.
    Chalise P; Fridley BL
    PLoS One; 2017; 12(5):e0176278. PubMed ID: 28459819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated Genomics for Pinpointing Survival Loci within Arm-Level Somatic Copy Number Alterations.
    Roy DM; Walsh LA; Desrichard A; Huse JT; Wu W; Gao J; Bose P; Lee W; Chan TA
    Cancer Cell; 2016 May; 29(5):737-750. PubMed ID: 27165745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficient exploration of pan-cancer networks by generalized covariance selection and interactive web content.
    Kling T; Johansson P; Sanchez J; Marinescu VD; Jörnsten R; Nelander S
    Nucleic Acids Res; 2015 Sep; 43(15):e98. PubMed ID: 25953855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tensorial blind source separation for improved analysis of multi-omic data.
    Teschendorff AE; Jing H; Paul DS; Virta J; Nordhausen K
    Genome Biol; 2018 Jun; 19(1):76. PubMed ID: 29884221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the clinical utility of genomic expression data across human cancers.
    Xu X; Huang L; Chan CH; Yu T; Miao R; Liu C
    Oncotarget; 2016 Jul; 7(29):45926-45936. PubMed ID: 27322207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A pan-cancer analysis of MYC-PVT1 reveals CNV-unmediated deregulation and poor prognosis in renal carcinoma.
    Posa I; Carvalho S; Tavares J; Grosso AR
    Oncotarget; 2016 Jul; 7(30):47033-47041. PubMed ID: 27366943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm.
    Martinez-Ledesma E; Verhaak RG; Treviño V
    Sci Rep; 2015 Jul; 5():11966. PubMed ID: 26202601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular subtyping for clinically defined breast cancer subgroups.
    Zhao X; Rødland EA; Tibshirani R; Plevritis S
    Breast Cancer Res; 2015 Feb; 17(1):29. PubMed ID: 25849221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The landscape and therapeutic relevance of cancer-associated transcript fusions.
    Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
    Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of ZG16 is associated with molecular and clinicopathological phenotypes of colorectal cancer.
    Meng H; Li W; Boardman LA; Wang L
    BMC Cancer; 2018 Apr; 18(1):433. PubMed ID: 29661177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Signatures for Tumor Classification: An Analysis of The Cancer Genome Atlas Data.
    Mamatjan Y; Agnihotri S; Goldenberg A; Tonge P; Mansouri S; Zadeh G; Aldape K
    J Mol Diagn; 2017 Nov; 19(6):881-891. PubMed ID: 28867603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.